The Frail Elderly Patient with Heart Disease

Brocklehurst's Textbook of Geriatric Medicine and Gerontology

Volumn , Issue , 2010, Pages 295-299

  Heckman, George A ^a   Rockwood, Kenneth ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959922916     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6231-8.10042-X     Document Type: Chapter

References (84)

1. Strong K., Mathers C., Leeder S., et al. Preventing chronic diseases: how many lives can we save?. Lancet 2005, 366:1578-1582.
2. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics 2008 update: a report from the American Heart Association statistics committee and strokes statistics subcommittee. Circulation 2008, 117:e25-e146.
3. American Heart Association: Heart disease and stroke statistics - 2003 update. Dallas, 2002, American Heart Association.
4. Heiat A., Gross C.P., Krumholz H.M. Representation of elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002, 162:1682-1688.
5. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887-1898.
6. Peters R., Beckett N., Forette F., et al. Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008, 7:683-689.
7. Skoog I. Antihypertensive treatment and dementia prevention. Lancet Neurol 2008, 7:664-665.
8. Lee H.Y., Cooke C.E., Robertson T.A. Use of secondary prevention drug therapy in patients with acute coronary syndromes after discharge. J Manag Care Pharm 2008, 14:271-280.
9. Sloane P.D., Gruber-Baldini A.L., Zimmerman S., et al. Medication undertreatment in assisted living settings. Arch Intern Med 2004, 164:2031-2037.
10. De Groote P., Isnard R., Assyag P., et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO study. Eur J Heart Fail 2007, 9:1205-1211.
11. Rapoport J., Jacobs P., Bell N.R., et al. Refining the measurement of the economic burden of chronic diseases in Canada. Chronic Dis Can 2004, 25:13-21.
12. Bergman H., Ferrucci L., Guralnik J., et al. Frailty: an emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007, 62A:731-737.
13. Newman A.B., Gottdiener J.S., McBurnie M.A., et al. Association of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001, 56A:M158-M166.
14. Purser J.L., Kuchibhatla M.N., Fillenbaum G.G., et al. Identifying frailty in older hospitalized patients with significant coronary artery disease. J Am Geriatr Soc 2006, 54:1674-1681.
15. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
16. Mitnitski A.B., Graham J.E., Mogilner A.J., et al. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2002, 2:1.
17. Goggins W.B., Woo J., Sham A., et al. Frailty index as a measure of biological age in a Chinese population. J Gerontol A Biol Sci Med Sci 2005, 60(8):1046-1051.
18. Kulminski A., Yashin A., Ukraintseva S., et al. Accumulation of health disorders as a systemic measure of aging: findings from the NLTCS data. Mech Ageing Dev 2006, 127(11):840-848.
19. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7-22. Heart Protection Study Collaborative Group.
20. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002, 360:1623-1630.
21. Rockwood K., Song X., MacKnight C., et al. A global measure of fitness and frailty in elderly people. Can Med Assoc J 2005, 173:489-495.
22. Silva M.A., Swanson A.C., Gandhi P.J., et al. Statin-related adverse events: a meta-analysis. Clin Ther 2006, 28:26-35.
23. Thavendiranathan P., Bagai A., Brookhart M.A., et al. Primary prevention of cardiovascular diseases with statin therapy. Arch Intern Med 2006, 166:2307-2313.
24. Harris T.B., Makuc D.M., Kleinman J.C., et al. Is the serum cholesterol-coronary heart disease relationship modified by activity level in older persons?. J Am Geriatr Soc 1991, 39:747-754.
25. Patterson C., Feightner J., Garcia A., et al. General risk factors for dementia: a systematic review. Alzheimer's Dementia 2007, 341:347.
26. Devereaux P.J., Anderson D.R., Gardner M.J., et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001, 323:1218-1222.
27. McCauley K.M., Bixby B.M., Naylor M.D. Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure. Dis Manag 2006, 9:302-310.
28. Arnold J.M.O., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45.
29. Hutcheon S.D., Gillespie N.D., Crombie I.K., et al. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 2002, 88:373-377.
30. Tanne D., Freimark D., Poreh A., et al. Cognitive functions in severe congestive heart failure before and after an exercise program. Int J Cardiol 2005, 103:145-149.
31. Gambassi G., Lapane K.L., Sgadari A., et al. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. Arch Intern Med 2000, 160:53-60.
32. Almeida O.P., Tamai S. Clinical treatment reverses attentional deficits in congestive heart failure. BMC Geriatr 2001, 1:2.
33. Zuccala G., Onder G., Marzetti E., et al. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 2005, 26:226-233.
34. Heckman G.A., Misiaszek B., Merali F., et al. Association between psychotropic drug use and heart failure therapy in elderly long-term care residents. J Am Geriatr Soc 2006, 54:1973-1975.
35. Selnes O.A., Royall R.M., Grega M.A., et al. Cognitive changes 5 years after coronary bypass surgery: is there evidence of late decline?. Arch Neurol 2001, 58:598-604.
36. Stygall J., Newman S.P., Fitzgerald G., et al. Cognitive change 5 years after coronary bypass surgery. Health Psychol 2003, 22:579-586.
37. Takagi H., Tanabashi T., Kawai N., et al. Cognitive decline after off-pump versus on-pump coronary artery bypass graft surgery: meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg 2007, 134:512-513.
38. Selnes O.A., Grega M.A., Bailey M.M., et al. Neurocognitive outcomes 3 years after coronary artery bypass graft surgery: a controlled study. Ann Thorac Surg 2007, 84:1885-1896.
39. The TIME Investigators: Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 2001, 358:951-957.
40. Pfisterer M., Buser P., Osswald S., et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs. optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003, 289:1117-1123.
41. Batchelor W.B., Anstrom K.J., Muhlbaier L.H., et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network collaboration. J Am Coll Cardiol 2000, 36:723-730.
42. Jarrett P.G., Rockwood K., Carver D., et al. Illness presentation in elderly patients. Arch Intern Med 1995, 155:1060-1064.
43. Tresch D.D. The clinical diagnosis of heart failure in older patients. J Am Geriatr Soc 1997, 45:1128-1133.
44. Resnick N.M. Urinary incontinence in the elderly. Med Grand Rounds 1984, 3:281-290.
45. Fujikawa K., Kasahara M., Matsui Y., et al. Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 2001, 35:310-313.
46. Thuresson M., Jarlow M.B., Lindahl B., et al. Symptoms and type of symptom onset in acute coronary syndromes in relation to ST elevation, sex, age, and a history of diabetes. Am Heart J 2005, 150:234-242.
47. Lindgren T.J., Fukuoka Y., Rankin S.H., et al. Cluster analysis of elderly cardiac patients' prehospital symptomatology. Nurs Res 2008, 57:14-23.
48. Malone M.L., Rosen L.B., Goodwin J.S. Complications of acute myocardial infarction in patients = 90 years of age. Am J Cardiol 1998, 81:638-641.
49. Tinker G.M. Clinical presentation of myocardial infarction in the elderly. Age Aging 1981, 10:237-240.
50. Bayer A.J., Chadha J.S., Farag R.R., et al. Changing presentation of myocardial infarction with increasing old age. J Am Geriatr Soc 1986, 23:263-266.
51. Wroblewski M., Mikulowski P., Steen B. Symptoms of myocardial infarction in old age: Clinical case, retrospective and prospective studies. Age Aging 1986, 15:99-104.
52. Aronow W.S. Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients. Am J Cardiol 1987, 60:1182.
53. Sheifer S.E., Gersh B.J., Yanez N.D., et al. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000, 35:119-126.
54. Arnold J.M.O., Howlett J.G., Dorian P., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure update 2007: prevention, management during intercurrent illness of acute decompensation, and use of biomarkers. Can J Cardiol 2007, 23:21-45.
55. Juurlink D.N., Mamdani M.M., Lee D.S., et al. Rates of hyperkalemia after the publication of the randomized aldactone evaluation study. N Engl J Med 2004, 351:543-551.
56. Mintzer J., Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000, 93:457-462.
57. Tune L.W. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001, 62(Suppl. 21):11-14.
58. Miura T., Kojima R., Sugiura Y., et al. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000, 34:427-432.
59. Tune L., Carr S., Cooper T., et al. Associations of anticholinergic activity of prescribed medications with postoperative delirium. J Neuropsychiatry Clin Neurosci 1993, 5:208-210.
60. Han L., McCusker J., Cole M., et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001, 161:1099-1105.
61. C.-j.L.u., Tune LE: Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry 2003, 11:458-461.
62. Tinetti M.E. Preventing falls in older persons. N Engl J Med 2003, 348:42-49.
63. Mukai S., Lipsitz L.A. Orthostatic hypotension. Clin Geriatr Med 2002, 18:253-268.
64. O'Mara G., Lyons D. Postprandial hypotension. Clin Geriatr Med 2002, 18:307-321.
65. Oates D.J., Berlowitz D.R., Glickman M.E., et al. Blood pressure and survival in the oldest old. J Am Geriatr Soc 2007, 55:383-388.
66. Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008, 7:246-255.
67. Hachinski V., Iadecola C., Petersen R.C., et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke: network vascular cognitive impairment harmonization standards. Stroke 2006, 37:2220-2241.
68. Heckman G.A., Patterson C.G., Demers C., et al. Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging 2007, 2:209-218.
69. Riegel B., Dickson V.V., Goldberg L.R., et al. Factors associated with the development of expertise in heart failure self-care. Nurs Res 2007, 56:235-243.
70. Dickson V.V., Tkacs N., Riegel B. Cognitive influences on self-care decision making in persons with heart failure. Am Heart J 2007, 154:424-431.
71. Alves T.C., Rays J., Telles R.M., et al. Effects of antidepressant treatment on cognitive performance in elderly patients with heart failure and comorbid major depression: an exploratory study. Psychosomatics 2007, 48:22-30.
72. Zuccala G., Onder G., Pedone C., et al. Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. J Neurol Neurosurg Psychiatry 2001, 70:109-112.
73. Zuccala G., Pedone C., Cesari M., et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003, 115:97-103.
74. Rozzini R., Sabatini T. Cognitive impairment and mortality in elderly patients with heart failure. Am J Med 2004, 116:137-138.
75. McLennan S.N., Pearson S.A., Cameron J., et al. Prognostic importance of cognitive impairment in chronic heart failure patients: does specialist management make a difference?. Eur J Heart Fail 2006, 8:494-501.
76. Vinson J.M., Rich M.W., Sperry J.C., et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990, 38:1290-1295.
77. Bennett S.J., Pressler M.L., Hays L., et al. Psychosocial variables and hospitalization in persons with chronic heart failure. Prog Cardiovasc Nurs 1997, 12:4-11.
78. Chin M.H., Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 1997, 87:643-648.
79. Cline C.M., Bjorck-Linne A.K., Israelson B.Y., et al. Non-compliance and knowledge of prescribed medications in elderly patients with heart failure. Eur J Heart Fail 1999, 1:145-149.
80. Naylor M.D. A decade of transitional care research with vulnerable elders. J Cardiovasc Nurs 2000, 14:1-14.
81. Bowles K.H., Naylor M.D., Foust J.B. Patient characteristics at hospital discharge and a comparison of home care referral decisions. J Am Geriatr Soc 2002, 50:336-342.
82. Papaioannou A., Uppaluri A. Pharmacological issues in the very old: the treatment of heart disease. Aging Issues in Cardiology 2004, Kluwer Academic Publishers, Boston. I.D. Turpie, G.A. Heckman (Eds.).
83. Naylor M.D., Brooten D.A., Campbell R.L., et al. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J Am Geriatr Soc 2004, 52:675-684.
84. Coleman E.A., Parry C., Chalmers S., et al. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med 2006, 166:1822-1828.